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BACKGROUND: The Cancer Fast-track Programme’s aim was to reduce the time that elapsed between well-founded suspicion of
breast, colorectal and lung cancer and the start of initial treatment in Catalonia (Spain). We sought to analyse its implementation and
overall effectiveness.
METHODS: A quantitative analysis of the programme was performed using data generated by the hospitals on the basis of seven fast-
track monitoring indicators for the period 2006–2009. In addition, we conducted a qualitative study, based on 83 semistructured
interviews with primary and specialised health professionals and health administrators, to obtain their perception of the programme’s
implementation.
RESULTS: About half of all new patients with breast, lung or colorectal cancer were diagnosed via the fast track, though the cancer
detection rate declined across the period. Mean time from detection of suspected cancer in primary care to start of initial treatment
was 32 days for breast, 30 for colorectal and 37 for lung cancer (2009). Professionals associated with the implementation of the
programme showed that general practitioners faced with suspicion of cancer had changed their conduct with the aim of preventing
lags. Furthermore, hospitals were found to have pursued three specific implementation strategies (top-down, consensus-based and
participatory), which made for the cohesion and sustainability of the circuits.
CONCLUSION: The programme has contributed to speeding up diagnostic assessment and treatment of patients with suspicion of
cancer, and to clarifying the patient pathway between primary and specialised care.
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Concern about the delay in diagnosis of cancer and its clinical and
psychosocial implications for patients has led a number of
European health systems to develop fast-track referral mechanisms
for patients with suspicion of cancer. In Catalonia, the Cancer Fast-
track Programme (CFP) was launched in 2005 for neoplasms
registering the highest incidence and mortality rates. The
incidence of breast, colorectal and lung cancer accounts for 43%
of all cancer incidence in women (28.1%,15.2% and 2.4%,
respectively) and 30% in men (13.9 and 16.1% in lung and
colorectal cancer) in Catalonia (Borra`s et al, 2008). The CFP’s aim
was therefore to reduce the time that elapsed between well-founded
suspicion of cancer and the start of initial treatment. To this end, a
time point (30 days) was set as a policy target for all patients
included in this special pathway, bearing in mind that there was no
universally predefined standard, and provided in all cases that the
characteristics of the specific diagnosis process allowed for this.
Despite the controversy surrounding such a programme’s
capacity to affect survival (Myrdal et al, 2004; Ramos et al,
2007), as initially suggested by the English National Health Service
(NHS Executive, 2000), aims other than the positive perception
that patients, professionals and policymakers have of a programme
of this type were also involved. On the one hand, better health-care
quality was sought, by reducing the variability in suspected-cancer
referral in primary care and achieving more standardised health-
care processes in secondary care; and on the other, the reduction
in waiting time was assumed to entail a reduction in the possible
psychosocial impact on the patient caused by a period of intense
anxiety and a sensation of vulnerability intervening between
suspicion of cancer, definitive diagnosis and the start of treatment,
a relationship supported by a number of studies (Risberg et al,
1996; Hislop et al, 2002; Barton et al, 2004; Cornford et al, 2004;
Brett et al, 2005). A relevant difference vis-a`-vis other European
experiences is that the development of the CFP includes the
treatment component, with the aim of preventing the imbalance
between greater diagnostic speed and problems that arise after
access to therapeutic resources, such as operating-theatre ‘bottle-
necks’, a frequent situation for fast-track procedures limited to
diagnosis (Chohan et al, 2005; Rai and Kelly, 2006; Olesen et al,
2009).
The Catalonian Health Service (CHS) is a universal health-care
system organised on the basis of the separation between public
funding/sponsorship and a mix of private- and publicly-owned
health facilities (foundations, consortia, and church- or publicly-run
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centres). It was this context that led the Department of Health to
permit circuits to be freely organised, subject in all cases to the use
of the referral guidelines agreed by experts from both care levels,
and the setting-up of a system of monitoring indicators.
This study analysed the overall effectiveness of the system, using
data sets that focused on the implementation of the colorectal,
breast and lung cancer fast tracks in Catalonia. It was considered
necessary to combine a quantitative assessment of programme-
monitoring data with a qualitative assessment of health profes-
sionals’ and administrators’ perception of the organisational
change entailed by the programme’s implementation. The policy
knowledge yielded by this analysis is expected to improve the
second phase of implementation, during which bladder and
prostate cancers are scheduled to be added to the programme.
Quantitative and qualitative methods stress the holistic and wide-
ranging approach needed to understand an innovative programme,
thanks to which health-service delivery has changed.
MATERIALS AND METHODS
The CFP was proposed as a means of reducing the lag (time
elapsed) between well-founded suspicion, diagnosis and treatment
of cancer, by designing circuits that would foster the rapid
coordination of the process circuit (see Figure 1). Similarly, the
health-care authorities had to issue some organisational recom-
mendations for effective implementation of these circuits, for
example, clinician responsible for disease, definition of maximum
waiting times for diagnosis, study without hospitalisation where
possible or coordination mechanisms in the event of referral to
another hospital. Furthermore, the development of the programme
implied the need to set up an information system, so that it could
be assessed on the basis of common indicators for the entire CHS.
Each hospital was required to submit aggregate data on patients
that entered into its circuit, with the recording and analysis of this
information being covered by programme funding, subject to
incentives in the prospective annual contract between the CHS and
the individual hospital. Three possible origins of suspicions for
routing fast-track patients were laid down, namely, primary care,
emergencies, or other clinical departments in routine monitoring
or screening. Detection meant that the patient in question had to
be referred to a ‘rapid diagnosis unit’ at a teaching hospital present
in each health region (decentralised health authorities of the CHS).
For study purposes, a fast-track circuit was defined as a process
that envisages a systematic approach to a complex pathology
involving two or more levels of care and several clinical
departments. A CFP seeks to synchronise the clinical needs of a
potential cancer patient, by implementing passive (e.g., slots in
diagnostic tests) or active measures (e.g., case management
throughout the care process), ultimately leading to improved
coordination.
Quantitative assessment
With regard to quantitative data sources, the following seven fast-
track monitoring indicators were laid down: number of patients
included in the CFP; cancer patients diagnosed through the CFP
route; patients referred from general practitioners (GPs); com-
pliance with referral guidelines; cancer detection rate; mean time
between detection of suspected cancer and start of treatment; and
distribution of the wait among different categories (‘over 30 days’,
‘30 to 45 days’ and ‘over 45 days’). Our analysis covered the period
2006– 2009. The hospitals were tasked with recording and sharing
these data with the primary-care level. Hospitals have reported
quantitative data to the CHS on an annual basis since 2006, with
the health regions having the obligation of ensuring the validity of
the data. Some clarifications must be made with regard to data
registration criteria. All new cancer diagnoses were included but
cases of relapse were excluded. Date of entry into the circuit
coincided with the referral date, and date of start of ‘treatment’
with the first treatment applied to the patient instead.
Qualitative evaluation
Qualitative study consisted of semistructured interviews con-
ducted from January to March 2009, with health professionals
drawn from primary and specialised care, and planning staff from
the health regions.
Data sources
A total of 83 health professionals were recruited from 18 fast
tracks. Professionals were deemed eligible if they participated in
fast-track management as stakeholders or data managers. For
selection of informants and composition of the purposive sample,
three inclusion criteria were established. To ensure that the views
of different health regions could be explored, the first criterion
ensured the presence of at least one fast track (primary and
specialised care) per health region. The second criterion reinforced
a systematic approach to the phenomenon under study, by
insisting on the presence of informants from each fast track
reflecting professional views, whether institutional, technical or
process-related (see Table 1). A final criterion to be considered was
the participation of different levels of hospitals, something that is
both appropriate and pertinent bearing in mind the usual fast-
track split between district and tertiary hospitals (e.g., thoracic
surgery in lung cancer). Participants were interviewed by an
experienced, qualitative researcher. The implementation of the
study began through contact with the hospital and local primary-
care directors, who proposed a short list of health professionals
selected in accordance with our criteria. The resulting list was
endorsed by the health regions. The health professionals
concerned were then sent a letter of invitation explaining the
research goals, together with a confidentiality agreement. The
consent form was formally signed at the meeting. No one refused
the invitation to participate.
Data-collection procedures
A semistructured interview ensured that all critical points were
addressed. To elicit beliefs and experiences, participants were
given the necessary flexibility to enable them to volunteer
information on topics of relevance to them. The health
Intra-hospital
track system
Primary care
Cancer suspicions
selection
Patient pathway
management
Coordination
Clinical criteria for
inclusion (cluster
symptoms by cancer)
Intra-hospital
referral
Referral track
Information
Diagnosis and
treatment
Figure 1 Scope and functions of the CFP.
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professionals selected were interviewed on a one-to-one basis for
45–75 min at the hospital or primary-care offices. Interviews
started with a general question on fast-track development and
ended with a question on how to introduce future changes to
improve the programme. No notes were taken by the researcher
during the interview; instead, all interviews were audiotaped and
transcribed in full. These data were then compiled into a
documentary record and rendered anonymous to protect con-
fidentiality. Every transcription was checked against its corre-
sponding sound recording, and accuracy was found to be good. A
preliminary analysis was conducted after each interview. All the
professionals selected for study purposes consented to the
interviews being recorded.
Analysis
Interview data were examined inductively. This process allowed for
data references to be labelled and developed for subsequent
analysis. Grounded theory methodology was considered appro-
priate for describing fast-track implementation and organisation
according to the professionals’ points of view. As our study was
theoretical and aimed at incorporating the organisational context
in which fast tracks had been implemented, we used axial coding,
as described by Strauss and Corbin (1998). Data were electronically
coded using the ATLAS.ti software programme (Muhr, 1997).
Grounded theory enabled language use to be understood and
professionals’ beliefs to be communicated; the constant compar-
ison method ensured that recurring views and experiences were
obtained. Thanks to the large number of interviews (83),
‘saturation’ of information was achieved (Guest et al, 2006). The
need to manage this amount of data and look for patterns entailed
to chart the coding data. While the coding process and emerging
themes were derived from issues raised by participants, the
properties and dimensions used to examine the data were drawn
from comparative fast tracks in the scientific literature. Examples
of codes were ‘dissemination of inclusion criteria in primary care’,
‘changes in the management of specialists’ diagnostic schedule’
and ‘case manager functions’. Coding/interpretation consistency
was checked during analysis, by reviewing the transcripts at
different points in time. To ensure the relevance and appropriate-
ness of the categories (first interpretative stage), health profes-
sionals from different disciplines were then asked to give their
considered opinion. Examples of categories used were ‘referring
patients performance’, ‘weaknesses in feedback between levels of
care’ and ‘hospital strategy for implementing the programme’. An
explanatory framework was thus identified by focusing our
analysis on patterns of the way in which action/interaction takes
place in every circuit and is aligned with organisational conditions
(e.g., setting a common gateway for suspected case referrals at
hospitals). A specific effort was made to capture this stage of
interpretation, that is, by mapping, creating typologies (Bryman
and Burgess, 1993) and finding associations among themes.
RESULTS
Quantitative monitoring
A total of 56 020 persons were included in the CFP during the
period 2006–2009. The results of the monitoring indicators
regarding circuit performance are presented in Table 2. The
degree to which the programme had been implemented increased
during the study period at the 65 hospitals in Catalonia, that is,
while there were complete data on 74% of hospitals attending to
Table 1 Detailed breakdown of the 83 professionals interviewed
From an institutional standpoint Professionals who received the order
to implement the fast track
Medical director 9 16
Programme coordinator (clinician) 7
From a technical standpoint Professionals who have led organisational
change towards fast-track development
Clinical leader (by tumour site) 19 22
Epidemiologist or quality analyst 3
From a process standpoint Professionals usually working with this
type of organisational approach
General practitioner 11 38
Specialist 12
Nurse case manager 12
Secretary or documentalist 3
Planning professionals from the health regions 7
Table 2 Monitoring indicators by type of cancer (2006–2009)
Tumour
site Year
Patients
included in
the CFP (n)
Cancer
diagnosed through
CFP routea
Patients
referred from
GPa
Compliance with
referral guidelinesa
Cancer
detection
ratea
Time between suspect
detection–treatment
start (mean days)
Colorectal cancer 2006 3642 42.0 (40.4–43.7) 60.1 (58.2–61.4) 77.3 (74.8–77.6) 40.7 (39.2–42.3) 30.4
2007 5903 50.1 (48.5–51.7) 61.1 (59.9–62.4) 76.1 (75.0–77.2) 32.9 (31.7–34.1) 29.1
2008 6786 45.2 (43.8–46.6) 59.6 (58.4–60.7) 77.0 (76.0–78.0) 29.3 (28.3–30.4) 27.1
2009 8077 54.3 (52.9–55.7) 60.7 (59.6–61.9) 80.6 (79.8–81.4) 28.7 (27.7–29.7) 29.6
Lung cancer 2006 3363 60.2 (59.8–63.4) 60.6 (59.0–62.3) 70.8 (69.1–72.1) 49.9 (48.2–51.6) 30.8
2007 2819 51.8 (50.0–53.7) 47.1 (45.3–49.0) 71.2 (69.5–72.8) 52.9 (51.1–54.7) 38.9
2008 3662 46.6 (45.0–48.2) 49.7 (48.1–51.3) 85.5 (84.4–86.7) 44.0 (42.5–45.6) 32.25
2009 3841 53.2 (51.5–54.9) 41.4 (39.7–42.9) 82.3 (81.1–83.5) 39.7 (38.1–41.2) 36.7
Breast cancer 2006 1581 38.4 (38.5–42.5) 48.3 (46.6–51.5) 81.1 (79.4–83.2) 51.5 (49.1–54.0) 35.7
2007 5225 60.4 (58.9–62.0) 52.4 (51.0–53.7) 86.5 (85.6–87.5) 45.0 (43.7–46.3) 31.8
2008 5416 56.8 (55.3–58.3) 54.1 (52.8–55.4) 92.3 (91.6–93.0) 40.2 (38.9–41.5) 31.5
2009 5705 58.2 (56.7–59.6) 42.8 (41.5–44.1) 87.9 (87.0–88.7) 44.0 (42.7–45.2) 32.1
Abbreviations: CFP¼Cancer Fast-track Programme; GP¼ general practitioner. aProportion (CI95%).
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cancer patients in 2006, this figure had risen to around 96% by
2009. The number of patients included in the programme
increased for all three neoplasms. Half or more of all new patients
with any of the three neoplasms were diagnosed via this pathway
across the period.
The proportion of patients referred by GPs across the entire
study period was B60% for colorectal versus 40 –50% for breast
and lung cancer. There is less variability among neoplasms in the
case of adherence to the clinical criteria for inclusion of possible
patients in the circuits, with the proportions being 470% in all
three cases. The cancer detection rate showed a statistically
significant moderate decreasing trend (Po0.001).
The results for the circuits in terms of waiting times are also
shown. Mean time from detection of suspected cancer in primary
care to start of initial treatment was under or a little over 30 days.
Lung cancer displayed a variable trend, albeit somewhat distant
from the 30-day target, something that is, in part, attributable to
the complexity of the treatment process, inasmuch as this includes
thoracic surgery concentrated at tertiary hospitals.
Lastly, the distribution of cases was considered by reference to
their proportions in terms of waiting times, specifically ‘over 30
days’; ‘30 to 45 days’ and ‘over 45 days’ (Figure 2). Breast cancer
was the only type that displayed a clearly positive trend. Lung
cancer registered variable figures, albeit worse overall; the data
revealed thatB50% of cases were divided between the two longest
wait categories, with this split being largely proportional.
Qualitative study
The CFP constitutes a formula for the virtual integration of
different levels of health-care providers. Compared to the
preceding situation, the implementation of circuits has meant a
new orientation of cancer processes on the basis of two basic
elements: on the one hand, primary care has a specific role vis-a`-
vis cancer by serving to detect suspected cases; and on the other,
the organisation of the intrahospital track implies a loss of control
of patient sources by clinical departments in favour of standardi-
sation of flows and the diagnostic process.
Primary care The creation of a specific track means that the way
in which it is used acquires great importance. Initially, hospital
professionals feared an overuse of the circuit in terms of referral of
suspected cases by GPs, whether owing to inaccurate matches to
guideline symptoms or inappropriate use of the route. The
majority opinion, however, is that this has not taken place, which
must, in good measure, be attributed to the set of actions
undertaken to differing degrees by the various health centres (see
Table 3). Indeed, of the circuits assessed, only one hospital was
observed to be overwhelmed as a result of overindication
(colorectal cancer).
The key to good acceptance of the programme in primary care
lies, according to the physicians in this area, in having an
instrument available that eliminates uncertainty (for both them
and their patients) surrounding the length of the course of care for
a potential cancer process. Indeed, the existence of these circuits
has altered and standardised such physicians’ conduct in the face
of suspicion of cancer. A total of 3 out of 12 GPs interviewed stated
that, before the programme’s introduction, it was a routine
procedure to request a mammogram in any case where there was
suspicion of breast cancer. Now, however, such a case would be
referred immediately so as to prevent the processes being delayed
any further by the health-care services.
In contrast, the feedback of clinical information from fast-
tracked patients at the primary-care level, during or on conclusion
of the diagnostic –therapeutic process, was viewed as deficient.
Feedback showed itself to be extremely unsystematic and subject
to the individual work practices of each hospital department.
Indeed, it was very usual for GPs to call the hospitals to enquire
about their patients’ progress. Furthermore, only 25% of the 18 fast
tracks assessed had a software programme in place that allowed for
the recording and multilateral consultation of clinical information
based on suspicion of cancer, which would normally make for the
smooth running of the interface at an operational level.
Specialised care The intrahospital stage of the circuit encom-
passes notification of suspected-cancer cases, organisation of the
patient pathway until final diagnosis, first treatment and feedback
to primary care. Among the changes implemented (Table 3),
mention should be made of identification of the ‘case management’
issue with the development of the programme, which took place at
13 of the 18 centres. Although case management was initially
performed on seven occasions by the nurse, on three occasions by
internal medicine and on three occasions by hospital adminis-
trative person monitoring, the nurse case–manager profile was
acknowledged as being a success and indeed has been extensively
implemented by most of the health centres in the period 2006–
2009. As a consequence of such assessment, nurse case–managers
exercised a key role in circuit cohesion, usually acting as the
gatekeeper of suspected case referrals and the reference point for
the patient and multidisciplinary team throughout the health-care
process. The necessary degree of professional autonomy in the
performance of their functions and poor delimitation of their
66.3%
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19.5%
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23.7%
25.5%
27.4%
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Figure 2 Waiting times in breast, lung and colorectal cancer (2006–2009).
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scope of competence in some cases led to adjustment problems at
some health centres.
The complexity inherent in the development of an ‘intrahospital
circuit’ made the choice of programme implementation strategy
extremely important. The logical premise expressed by the leaders
was that the more the various stakeholders and policymakers were
involved in co-designing and implementing the circuits, the
greater the amount of objective changes that could be made to
the health-care process and the greater the satisfaction that would
be felt by health professionals regarding the previous situation.
Three strategies were identified in the 18 circuits analysed:
 Top-down (n¼ 5), where hospital management designed a flow
chart and implementation programme in the territory, which
was then transferred to the clinical teams.
 Consensus-based (n¼ 10), where the clinicians responsible led
the process of change, with the institutional support of hospital
management.
 Participatory (n¼ 3), where a leader was appointed and an
implementation committee was set up, on which all the clinical
departments were represented. The committee then proceeded
to act on a horizontal, cross-department basis.
There are two elements of note in the assessment of the above
strategies. On the one hand, the top-down and, in good measure,
consensus-based strategies tended to limit the spread of knowledge
of guidelines and intra-referral mechanisms among the clinical
departments potentially involved, something that could negatively
affect identification and effective referral of patients with suspicion
of cancer. On the other hand, only the participatory strategy
ensured an integrated development of the three diseases based on
the rationale of a single circuit. Most of the interviewees were of
the opinion that the logic of ‘three pathways, one circuit’ was
prejudiced, when clinical and professional leaders who had to
work together within the circuits were perceived as acting without
a common reference framework, which occurred at 7 of the 18
hospitals analysed. Properly speaking, one is referring here to
three ‘circuits’, that is, three distinct pathways, depending on the
disease in question. Where there is such variability, organisational
changes remain subject to the enthusiasm of the health profes-
sionals in charge of each disease. Indeed, some ‘circuits’ displayed
an organisation that was substantially better than others, a
situation that may make for inequities of care, in terms of the
programme’s overall effectiveness (impact on waiting times, cancer
detection rate, etc.).
DISCUSSION
This assessment seeks to give an account of the implementation
process of the fast-track cancer diagnosis and treatment pro-
gramme, which was initiated in 2006 and has been positively
assessed by health-care system stakeholders and policymakers as a
whole. Half of all colorectal, lung and breast cancer patients are
diagnosed today within periods of B30 days (longer in lung
cancer) via a fast-track route created among care levels, which has
made a considerable contribution to clarifying and accelerating
cancer diagnosis and treatment. There will always be patients who
cannot be diagnosed within the CFP but, on being incorporated
once diagnosis has been made, they will nevertheless be able to
take advantage of the enhanced speed to treatment and the greater
degree of integration achieved by the entire patient pathway, with
an implicit goal being to prevent the creation of a two-tier system
in which routine referrals might be adversely affected in terms of
waiting time (Jones et al, 2001). Evidence indicates that failure to
recognise cancer symptoms in referral can double the wait to
initiation of treatment (Pullyback et al, 2003). As Gomez et al
(2010) conclude, ‘the kind of health-care system and the referral
scheme (simple, clear, fast) for those suspected of cancer are
relevant’.
One of the key aspects of the programme is regular assessment.
Studies examining delays are difficult to compare because of the
different end points used, for example, to start with, most are
confined to the diagnostic component. Looking at the reference
model for fast-track (cancer suspected) referral, namely, the
English National Health Service’s Two Week Rule (TWR) (NHS
Executive, 1999), differences will be observed between this and
Catalonia’s experience in certain aspects. In the case of colorectal
cancer, Thorne et al (2006) review grouped eight studies (period
2000– 2003). Of the 2440 fast-tracked patients, 24.1% were
diagnosed through the GP route and the cancer detection rate
was 10.3%. Rai and Kelly (2006) grouped seven health centres
(period 2003– 2005) for a total of 1814 fast-tracked patients: in no
case did the contribution of the TWR system to total colorectal
cancer detection exceed 50%, the cancer detection rate ranged
from 4.6 to 11%, and guideline adherence was 41–96%. Our study
registered data which were significantly higher in terms of GP
referral (around 60%) and cancer detection rates (around 30%),
and similar in terms of adherence to referral guidelines. In breast
cancer, the 5-year study (period 1999–2005) conducted by Singhal
et al (2008) covered 6678 patients, 46.7% of the total seen in the
period. The cancer detection rate was 16.4%, and guideline
Table 3 Organisational innovation along the different stages of the fast-track process
Specific changes Key objectives
From suspected cancer detection to confirmation of diagnosis
Clinical discussion of guidelines in multidisciplinary groups of both levels of care
Generation and dissemination of information High degree of compliance with clinical guidelines
Review and updating of inclusion criteria
Unification of hospital-access gateways Effective referral to diagnosis between care levels
Direct electronic access to outpatient appointment or a single clear pro-forma
Discussion of referral track by clinicians and data-processing staff of both levels
(to prevent lags as a result of administrative errors)
From confirmation of diagnosis to first treatment
Protocolisation of diagnostic tests
Establishment of a ‘triple priority’, that is, rapid diagnosis of high, low probability and ordinary list Improving the queuing mechanisms for accessing services
Slots in schedules for diagnostic tests and rechanelling to the ordinary list in the event of cancellation
Operating-theatre slottings Preventing operating theatre bottle –necks
Extension of knowledge of referral guidelines and referral track to all possible origins
of suspicions at the hospital
Effective referral to diagnosis between clinical departments
Case management (notification of referrals, patient counselling, coordination of appointment
schedule and tumour committee role)
Improving coordination and speed of processes
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adherence was 71.9%. Our data were similar in terms of GP referral
(42.8% in 2009) and guideline adherence, though the cancer
detection rate was significantly higher (over 40% in all cases). One
of the factors that might partly account for the difference in the
detection rate is that the CFP not only encompasses cases
originating in GP referral, but also those stemming from screening
or emergencies. Also, the statistically significant decrease of the
detection rate reflected the process of the program’s implementa-
tion; to better assess this trend a longer period of time would be
required. Experts are of the opinion that, while efforts in reducing
the delay in lung cancer care do not impact on patient prognoses
(Myrdal et al, 2004; Salomaa et al, 2005; Gonza´lez-Barcala et al,
2010), there is nevertheless convincing evidence to show that for
some potentially curable patients delays at this point can decrease
their chances of survival (O’Rourke and Edwards, 2000). Accord-
ingly, it is essential that such efforts be sustained (Moody et al,
2004). Although there is no convincing evidence that rapid
diagnosis of colorectal cancer improves prognosis (Ramos et al,
2007), a higher risk of death has nonetheless been observed when
the delay is longer than 5 weeks in patients with suggestive
symptoms (Tørring et al, 2011).
This study has some limitations. Insofar as the quality of the
quantitative data is concerned, the statistical analyses were
performed using the overall data available. Progressive implemen-
tation did not allow for an analysis of the data with a breakdown
by hospital (e.g., in the case of the hospitals chosen for the
qualitative study). A further limitation was the lack of a procedure
for validating the data generated by the hospitals. Similarly, there
is no regulation requiring hospitals to generate data on patients
not included in the circuits, information that would enable one to
ascertain whether such patients undergo a far longer diagnostic or
therapeutic delay or are diagnosed at a more advanced stage of the
disease. This also hinders comparison between the CFP and the
performance of other fast-track processes. A clear limitation of the
qualitative study lay in the selection process, which was based on
proposals put forward by hospital managers and programme
coordinators, and could have biased the choice of professionals
towards those sensitive to the programme’s effective implementa-
tion. The selection criteria specifically designed to target different
profiles were intended to minimise this limitation. Our research
focused on the views of professionals from 18 fast-track routes,
thereby implicitly ruling out the possibility of capturing all the
experiences and best practices that might exist in the health system
as a whole.
Several important lessons were learned from this experience.
The distinctive feature recognisable in the best hospital imple-
mentation strategies is their horizontal, cross-department mode of
operation. From these hospitals’ experience, we know that it is
essential not only to ensure a vertical approach to the process
(accelerating it with new ways of channelling suspected cases
between units, or relying upon on nurse case managers), but also
to make provision for horizontal integration, especially among
treatment hospital departments. At all events, caution must be
exercised in establishing a causal relationship between implemen-
tation strategy in hospitals and quantitative results, as health-care
organisation culture – which is hierarchical to a greater or lesser
degree and guides individual behaviour within such organisations
– tends to intervene in this relationship. Lastly, the implementa-
tion of the CFP involves an exercise in prioritisation for health
administrators, that is, on the one hand, the inclusion of the first
treatment within the 30-day reference period places a certain
degree of stress on the management of operating-theatre schedules
and the availability of certain health professionals, something that
is also borne out by a qualitative study (Cornford et al, 2004); and
on the other, the programme incentive system envisaged by the
health authorities can sometimes clash with those already
introduced for other illnesses. The result is a certain degree of
‘competition’ among diseases at general hospitals.
Prompt diagnosis and treatment of patients with suspicion of
cancer has, in essence, amounted to a commitment to the
generalisation of process-based management among care levels.
This change was in contrast to the initial scepticism of health
professionals, who saw it as simply formalising something that had
already existed informally. However, this has led to a marked
qualitative leap in their opinion, though no data are available on
delay times before programme implementation. Despite the
implementation problems outlined here, the circuits have suc-
ceeded in impacting positively on health service delivery, some-
thing that needs to be weighed on the basis of improving
monitoring indicators and providing data on patients not included
in the circuits. This would give us a valuable knowledge in terms of
potential delays in other cancer patients. At all events, unnecessary
or unexplained delays are now being perceived as a matter of
concern by all cancer patients (Borra`s et al, 2010), as is indeed
recognised in the Catalonian Cancer Plan (2009).
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